Aurinia Pharmaceuticals Inc. (AUPH) Financials

NASDAQ Currency in USD Disclaimer

$8.98

north_east $0.03 (0.34%)
Day's range
$8.9
Day's range
$9.01

AUPH Income statement / Annual

Last year (2023), Aurinia Pharmaceuticals Inc.'s total revenue was $175.51 M, an increase of 30.95% from the previous year. In 2023, Aurinia Pharmaceuticals Inc.'s net income was -$78.02 M. See Aurinia Pharmaceuticals Inc.�s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $175.51 M $134.03 M $45.61 M $50.12 M $318,000.00 $463,000.00 $420,000.00 $173,000.00 $235,000.00 $278,000.00
Cost of Revenue $14.15 M $5.66 M $1.09 M $50.33 M $52.87 M $41.38 M $1,000.00 $4,000.00 $12,000.00 $37,000.00
Gross Profit $161.37 M $128.37 M $44.51 M -$209,000.00 -$52.55 M -$40.92 M $419,000.00 $169,000.00 $223,000.00 $241,000.00
Gross Profit Ratio 0.92 0.96 0.98 -0 -165.25 -88.38 1 0.98 0.95 0.87
Research and Development Expenses $49.64 M $44.99 M $51.14 M $50.33 M $52.87 M $41.38 M $33.93 M $14.53 M $15.98 M $9.11 M
General & Administrative Expenses $195.04 M $196.37 M $171.44 M $95.98 M $22.15 M $13.67 M $12.10 M $6.97 M $6.26 M $6.89 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $195.04 M $196.37 M $171.44 M $95.98 M $22.15 M $13.67 M $12.10 M $6.97 M $6.26 M $6.89 M
Other Expenses $8.38 M -$1.52 M $2.67 M $1.29 M $1.55 M $2.07 M $195,000.00 -$1.63 M -$337,000.00 -$848,000.00
Operating Expenses $253.06 M $239.84 M $225.25 M $147.60 M $76.57 M $56.62 M $47.48 M $22.98 M $23.80 M $17.52 M
Cost And Expenses $267.20 M $245.50 M $226.34 M $147.60 M $76.57 M $56.62 M $47.48 M $22.99 M $23.82 M $17.56 M
Interest Income $17.00 M $5.12 M $529,000.00 $1.52 M $2.70 M $2.23 M $1.04 M $27,000.00 $50,000.00 $65,000.00
Interest Expense $2.78 M $5.12 M $0.00 $0.00 $39,000.00 $2.23 M $702,000.00 $27,000.00 $50,000.00 $30,000.00
Depreciation & Amortization $11.65 M $2.71 M $2.76 M $1.37 M $1.17 M $1.57 M $1.46 M $1.48 M $1.56 M $1.52 M
EBITDA -$63.05 M -$103.65 M -$177.45 M -$102.92 M -$89.77 M -$53.93 M -$45.61 M -$21.34 M -$22.02 M -$15.70 M
EBITDA Ratio -0.36 -0.83 -3.92 -1.92 -254.69 -96.41 -51.63 -120.39 -114.66 -56.46
Operating Income Ratio -0.52 -0.83 -3.96 -2.08 -259.56 -121.29 -112.05 -131.87 -100.34 -62.17
Total Other Income/Expenses Net $14.22 M $5.12 M $529,000.00 $1.52 M $2.70 M $2.23 M -$23.73 M -$481,000.00 $4.97 M -$2.14 M
Income Before Tax -$77.47 M -$106.35 M -$180.21 M -$102.77 M -$123.70 M -$64.05 M -$70.79 M -$23.30 M -$18.61 M -$16.65 M
Income Before Tax Ratio -0.44 -0.79 -3.95 -2.05 -389 -138.33 -168.55 -134.65 -79.18 -59.88
Income Tax Expense $551,000.00 $1.83 M $760,000.00 -$94,000.00 $144,000.00 $73,000.00 $23.92 M $481,000.00 -$4.97 M $30,000.00
Net Income -$78.02 M -$108.18 M -$180.97 M -$102.68 M -$123.85 M -$64.12 M -$70.79 M -$23.30 M -$18.61 M -$16.65 M
Net Income Ratio -0.44 -0.81 -3.97 -2.05 -389.45 -138.49 -168.55 -134.65 -79.18 -59.88
EPS -0.54 -0.76 -1.4 -0.87 -1.33 -0.76 -0.92 -0.66 -0.58 -0.57
EPS Diluted -0.54 -0.76 -1.4 -0.87 -1.33 -0.76 -0.92 -0.66 -0.58 -0.57
Weighted Average Shares Out $143.24 M $141.92 M $129.37 M $118.47 M $93.02 M $84.78 M $76.92 M $35.29 M $32.15 M $28.99 M
Weighted Average Shares Out Diluted $143.24 M $141.92 M $129.37 M $118.47 M $93.02 M $84.78 M $76.95 M $35.29 M $32.15 M $29.16 M
Link